Our focus is on improving human health, quality and productivity using related DNA-marker technologies. These products will form an important part of Pfizer’s integrated approach to animal management—combining DNAmarker assisted selection with phenotypic evaluations to develop more precise ways of predicting the genetic potential for animal health, quality and productivity.